Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals
Abstract
Abstract The use of at least one compound of Formula (I) for the manufacture of a medicament for controlling and/or reducing a patient's serum cholesterol and/or triglyceride level is disclosed. <CHEM> wherein Y is O or NH, R is OH, NHCONR<4>R<5>; or N=C(NR<4>R<5>)2;where R<4> and R<5> are each independently selected from the group consisting of hydrogen; C1-10alkyl, straight or branched chain; aryl C1-4alkyl; mono- or disubstituted aryl C1-4 alkyl where the substituents are fluoro, chlore, bromo, iodo, or C1-10alkyl, straight or branched chain; R<1> and R<2> are each independently selected from the group consisting of hydrogen, animo, and mono- or di-substituted amino where the substituents are C1-10alkyl, straight or branched chain, C3-8 cycloalkyl; provided that R<1> and R<2> may not both be amino or substituted amino and; R<3> is hydrogen, trifluoromethyl, fluoro; chloro, bromo, or iodo, or a pharmaceutically acceptable salt thereof. e
Inventors
- 👤 Karl H. Beyer, Jr.
Bibliographic Details
Claims Analysis
Total Claims: 7References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-04-23 | 1993-10-23 | 1994-04-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-04-23 | 1997-10-23 | 1998-04-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-04-23 | 2001-10-23 | 2002-04-24 | $7700.00 | Window Closed / Lapsed |